Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3670

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3670 3)

Pdp (68071 3670 3)
This is a detailed information on Sildenafil 25mg tablets manufactured by CarePharmaceuticals, Inc. The provided data includes lot numbers, NDC numbers, manufacturer information, expiration dates, serial numbers, and a warning to store the medication at a controlled temperature of 68-77°F and to keep it out of reach of children. Additionally, the text suggests contacting a doctor for medical advice and provides a contact number for reporting side effects to the FDA.*
FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Sildenafil_fig1.jpg (Sildenafil Fig1)
This is a graph showing the average change in sitting systolic blood pressure over time for healthy volunteers who were administered either 100mg of Sildenafil or a placebo. The x-axis represents the time post-dose in hours, and the y-axis represents the systolic blood pressure in mmHg. The data is displayed for 4, 8, 12, 16, and 20 hours post-dose.*
FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Sidenafil_fig_5 (Sildenafil Fig 5)
This text mentions Figure 5 which presents the mean Sildenafil plasma concentrations in healthy male volunteers. This figure likely provides valuable information regarding the pharmacokinetics or drug levels of Sildenafil in a research setting.*
FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Sildenafil-fig7 (Sildenafil Fig7)
Percentage patients reporting improvement: - Placebo: 4% - Sidenail: 63% - Sideral Tablets 25mg: 24% - Sitdari Tablets: 2% This text provides information on the percentage of patients reporting improvement with different medications.*
FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.